Ładuje się......
Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis
Denosumab is a human monoclonal antibody which specifically blocks receptor activator of nuclear factor κB ligand and is a very potent antiresorptive drug. Its efficacy in reducing the risk of vertebral, hip and nonskeletal fracture has been proven in a large prospective, randomized multicenter stud...
Zapisane w:
| Wydane w: | Ther Adv Musculoskelet Dis |
|---|---|
| 1. autor: | |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
SAGE Publications
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4426099/ https://ncbi.nlm.nih.gov/pubmed/26029270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X15579189 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|